Long-term ritlecitinib was generally well tolerated among patients aged 12 years and older with alopecia areata and showed clinically meaningful efficacy through 3 years. Treatment with ritlecitinib ...

Please provide your email address to receive an email when new articles are posted on . A phase 3 study compared two doses of ivarmacitinib with placebo in 330 adults. At week 24, about 35% in the ...

In June 2023, the FDA approved ritlecitinib (Litfulo, Pfizer) for participants with severe alopecia aged 12 years and older, but “there is still a very important medical need” for more options ...

List of useful data augmentation resources. You will find here some not common techniques, libraries, links to GitHub repos, papers, and others. This repository collects papers for "A Survey on ...

State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, Gansu, P. R. China ...

This is a framework for RTL synthesis tools. It currently has extensive Verilog-2005 support and provides a basic set of synthesis algorithms for various application domains. Yosys can be adapted to ...

Hubei Key Laboratory of Resources and Chemistry of Chinese Medicine, College of Pharmacy, Hubei Shizhen Laboratory, Hubei University of Chinese Medicine, Wuhan 430061, China Institute for Safflower ...

IBD (inflammatory bowel disease) is a chronic inflammatory disease of the gastrointestinal tract with increasing incidence worldwide. Multiple factors, such as genetic background, environmental and ...